Get the Stockscreener App
2.125
7.21%
-0.165
After Hours:
2.12
-0.005
-0.24%
Codexis Inc stock is traded at $2.125, with a volume of 1.25M.
It is down -7.21% in the last 24 hours and down -20.71% over the past month.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.29
Open:
$2.21
24h Volume:
1.25M
Relative Volume:
1.47
Market Cap:
$176.03M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-1.9144
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
-24.38%
1M Performance:
-20.71%
6M Performance:
-32.75%
1Y Performance:
-33.80%
1-Day Range:
$2.00
$2.25
1-Week Range:
$2.00
$2.78
52-Week Range:
$2.00
$6.08
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.125 | 176.03M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Codexis sees significant stock purchase by Opaleye Management, Inc. for $271,788 - Investing.com South Africa
Codexis stock hits 52-week low at $2.43 amid market challenges - Investing.com Australia
Protein Engineering Market Is Booming So Rapidly | Major Giants Merck KGaA, Agilent Technologies, Codexis - newstrail.com
Codexis Appoints Cynthia Collins to Board of Directors - GlobeNewswire
RNA Pioneer and Former Editas CEO Joins Codexis Board: Strategic Move for RNA Therapeutics Push - Stock Titan
Codexis appoints new independent board member By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Purchases 26,052 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis appoints new independent board member - Investing.com
Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Holdings Increased by Bank of New York Mellon Corp - Defense World
Codexis sees $236,283 in stock purchases by Opaleye management - Investing.com Australia
Opaleye Management Inc. Expands Stake in Codexis Inc. - GuruFocus
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - GlobeNewswire
New Contract Propels Codexis (CDXS) Stock Upward, Signaling Market Optimism - Stocks Telegraph
Codexis Signs First Contract for ECO Synthesis Manufacturing Services -March 24, 2025 at 08:17 am EDT - MarketScreener
Codexis Inc (NASDAQ: CDXS): Should Value Hunters Buy It? - Stocks Register
Codexis Achieves Major Revenue Milestone: First ECO Synthesis Contract Signals Market Breakthrough - StockTitan
Opaleye Management Inc. Increases Stake in Codexis Inc. - GuruFocus
Codexis stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa
Codexis stock hits 52-week low at $2.47 amid market challenges - Investing.com India
Opaleye Management Inc. Boosts Investment in Codexis with Major Stock Purchase - TipRanks
Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World
Codexis sees $261,350 stock acquisition by Opaleye management - Investing.com Australia
Codexis sees $261,350 stock acquisition by Opaleye management By Investing.com - Investing.com South Africa
Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News
Major Shareholder Makes Bold Move with Codexis Stock Purchase! - TipRanks
Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances - GuruFocus.com
Rhumbline Advisers Boosts Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis Announces New Employment Inducement Grants - GlobeNewswire
Codexis grants equity to new hires under inducement plan - Investing.com India
New Hires at Codexis Receive Significant Equity Compensation Package - StockTitan
FY2025 EPS Estimates for Codexis Raised by Cantor Fitzgerald - Defense World
Codexis sees $172,273 stock purchase by Opaleye management - Investing.com
Codexis sees $172,273 stock purchase by Opaleye management By Investing.com - Investing.com South Africa
Things To Consider Before Buying Codexis Inc (NASDAQ: CDXS) - Stocks Register
Codexis at TD Cowen Conference: Enzymatic Innovation in siRNA Manufacturing - Investing.com
This trade activity should not be overlooked: Codexis Inc (CDXS) - SETE News
Codexis stock touches 52-week low at $2.55 amid market challenges - Investing.com Australia
Codexis Inc: Is CDXS Stock Worth Buying? - Stocks Register
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Top 5 Synthetic Biology Public Companies (March 2025) - Securities.io
Codexis (NASDAQ:CDXS investor three-year losses grow to 84% as the stock sheds US$93m this past week - Simply Wall St
When Will Codexis, Inc. (NASDAQ:CDXS) Become Profitable? - Yahoo Finance UK
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):